|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.360 USD | -1.75% |
|
+1.82% | -8.20% |
| 05-14 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 112M | - | - | - | ||
| 68.85B | |||||
| 52.13B | |||||
| 43.46B | |||||
| 41.24B | - | ||||
| 30.41B |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
